Financials
- Market Capitalization 95.35 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.38
ratio cours/chiffre d'affaires
18.82
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3873 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.77 USD | -4.94% | -1.28% | -22.22% | -61.11% | 95.86 M USD | ||
| 3875 | ICCC ImmuCell Corporation - Common Stock | 10.50 USD | +9.38% | +5.32% | +7.14% | +54.64% | 95.36 M USD | ||
| 3879 | ANIX Anixa Biosciences, Inc. - Common Stock | 2.73 USD | -3.87% | -10.49% | -2.15% | -39.06% | 94.91 M USD | ||
| 3895 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 8.81 USD | -6.08% | -6.97% | -3.08% | -40.27% | 88.43 M USD |